|
|
NAVB Oldtimers Lounge
|
|
||
Postive! BIND gone from CRG type lawsuit but NAVB here. Repeat Bind CEO view of Manocept: Terming Manocept under Breakthrough Therapies to kill bad macrophages or force bad macrophages into anti-tumoral...something special...Used "exciting" twiceMsg 9146 of 19758 at 9/17/2015 11:54:39 AM by
Re: BIND CMO at CEN Conf. Sept 16: Terming Manocept under Breakthrough Therapies to kill bad macrophages or force bad macrophages into anti-tumoral...something special...Used "exciting" twice... insideout thanks. When
both companies keep using words excited and exiting and Bind has
repeatedly said "something special" when discussing MC and
inter-cellular; it says a lot if the reader understands the world wide
credentials of the Bind co founders (in fact Langer has been mentioned
in the same sentence as Nobel in some circles) and the type of
credentials their technical team would carry making these comments BIND CMO at CEN Conf. Sept 16: Terming Manocept under Breakthrough Therapies to kill bad macrophages or force bad macrophages into anti-tumoral...something special...Used "exciting" twice...Also confirmed Accurin is 100 nm. Cannot yet pass BBB, but stay turned working on that 5th from last presentation-lasts 1 hour;; MC review around 47 minutes---have to register-worth the time Warning Will Robinson, Warning--technical conference |
return to message board, top of board |